Mesoblast reported 62.56M in Cash and Equivalent for its fiscal semester ending in June of 2024.


Cash And Equivalent Change Date
Avita Medical AUD 14.05M 3.4M Dec/2024
Clinuvel Pharmaceuticals AUD 35.2M 3.62M Jun/2024
Cochlear AUD 383.1M 130.5M Dec/2024
CSL 1.52B 133M Dec/2024
Pacific Edge NZD 22.57M 637K Mar/2025
Paradigm Biopharmaceuticals 17.82M 15.73M Jun/2024
PYC Therapeutics AUD 49.25M 17.62M Dec/2024
Ramsay Health Care AUD 341.1M 321.2M Dec/2024
Sonic Healthcare 645M 25.39M Jun/2024
Starpharma Holdings AUD 20.28M 3.08M Dec/2024
Telix Pharmaceuticals 710.35M 587.11M Dec/2024